Trell, Erik
October 1972
Angiology;Oct1972, Vol. 23 Issue 9, p558
Academic Journal
Focuses on a condition concerning primary and chronic thromboembolic pulmonary hypertension. Percentage of the pulmonary arteries be blocked with thrombotic material before significant pulmonary hypertension develops; Likelihood of reflex pulmonary hypertension to be mediated through histamine; Occurrence of primary and thromboembolic pulmonary hypertension in association with aminorex.


Related Articles

  • Value and Limitations of Calcium Channel Blockade In the Treatment of Pulmonary Hypertension Associated with CREST - Case Reports. Pressly, Thomas A.; Winkler, Anne; Alpert, Martin A.; Jackson, Robert W.; Mukerji, Vaskar; Benge, J. Michael; Sharp, Gordon C. // Angiology;Apr1988, Vol. 39 Issue 4, p385 

    Reversible vasospasm has been hypothesized to underlie the development of pulmonary hypertension in patients with CREST. Drugs that prevent arterial spasm have been used to treat pulmonary hypertension with variable results. The disparate pulmonary hemodynamic responses to calcium channel...

  • Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension. Cool, Carlyne D.; Rai, Pradeep R.; Yeager, Michael E.; Hernandez-Saavedra, Daniel; Serls, Amanda E.; Bull, Todd M.; Geraci, Mark W.; Brown, Kevin K.; Routes, John M.; Tuder, Rubin M.; Voelkel, Norbert F. // New England Journal of Medicine;9/18/2003, Vol. 349 Issue 12, p1113 

    Background: Severe pulmonary hypertension constitutes a group of diseases characterized by complex, lumen-occluding vascular lesions that develop in genetically susceptible persons. The only viral infection associated with severe pulmonary hypertension has been that due to human immunodeficiency...

  • Clinical Case Studies in Renal Transplantation.  // Advances in Pulmonary Hypertension;Summer2013, Vol. 12 Issue 2, p75 

    The article presents several case studies from the articles "Pulmonary Hypertension in Patients with Chronic Kidney Disease: Noninvasive Strategies for Patient Phenotyping and Risk Assessment," by Amresh Raina, and "Hemodynamic Evaluation of Pulmonary Hypertension in Chronic Kidney Disease," by...

  • Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 4, p140 

    The article presents a study that investigates the effects of exercise training on the capacity and quality of life in inoperable or residual chronic thromboembolic pulmonary hypertension (CTEPH) patients. It details the method of the non-randomized study that observes 35 patients with...

  • Pulmonary Hypertension in Cardiac Surgery. Denault, Andr´┐Ż; Deschamps, Alain; Tardif, Jean-Claude; Lambert, Jean; Perrault, Louis // Current Cardiology Reviews;2010, Vol. 6 Issue 1, p1 

    Pulmonary hypertension is an important prognostic factor in cardiac surgery associated with increased morbidity and mortality. With the aging population and the associated increase severity of illness, the prevalence of pulmonary hypertension in cardiac surgical patients will increase. In this...

  • Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia. Hallowell, Robert W.; Reed, Robert M.; Fraig, Mostafa; Horton, Maureen R.; Girgis, Reda E. // Pulmonary Circulation;2012, Vol. 2 Issue 1, p101 

    Pulmonary hypertension (PH) is a common complication of interstitial lung disease (ILD), particularly in idiopathic pulmonary fibrosis (IPF) and ILD associated with connective tissue disease, where the underlying pathology is often a nonspecific interstitial pneumonia (NSIP) pattern. The degree...

  • Nutritional Assessment in Patients With Pulmonary Arterial Hypertension Facing Transplantation. Coplan, Beth; Studer, Sean // Advances in Pulmonary Hypertension;Summer2013, Vol. 12 Issue 2, p96 

    The article cites a research study that discusses the ideal diet for patients with pulmonary arterial hypertension facing transplantation. It is said that clinicians treating patients with pulmonary arterial hypertension (PAH) are very likely to encounter patients who are obese or underweight....

  • Comparison of pulmonary vascular function and structure in early and established hypoxic pulmonary hypertension in rats. Jeffery, Trina K; Wanstall, Janet C // Canadian Journal of Physiology & Pharmacology;Mar2001, Vol. 79 Issue 3, p227 

    In pulmonary hypertension, changes in pulmonary vascular structure and function contribute to the elevation in pulmonary artery pressure. The time-courses for changes in function, unlike structure, are not well characterised. Medial hypertrophy and neomuscularisation and reactivity to vasoactive...

  • Recent Phase 3 Results. Levine, Deborah J.; Torres, Fernando // Advances in Pulmonary Hypertension;Summer2013, Vol. 12 Issue 2, p53 

    The article examines the PATENT-1 study results related to treatment of pulmonary hypertension (PH), and findings from CHEST-1, and outcomes of the SERAPHIN trial. It highlights results of treating patients with riociguat for pulmonary arterial hypertension (PAH). Also the treatment of chronic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics